Evelo Biosciences, Inc.

OTCPK:EVLO 株式レポート

時価総額:US$7.6k

Evelo Biosciences マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間4.8yrs
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Aug 18
Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Evelo Biosciences GAAP EPS of -$0.40 beats by $0.03

Aug 11

Marella Thorell is the new finance chief of Evelo Biosciences

Jul 18

Evelo Biosciences: Hope After Dilution?

Jun 06

Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Mar 21
Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

Sep 25
Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Mar 11
What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Evelo Bio secures ~$67.5M capital raise

Jan 29

Evelo Biosciences expands EDP1815 mid-stage trial to atopic dermatitis

Jan 07

Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Dec 15
Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Dec 11
Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Evelo Biosciences identifies new lead oncology candidate

Dec 09

Evelo Bio's EDP1815 completes enrollment targeting interim data in mid-stage psoriasis study

Dec 03

Evelo Biosciences EPS beats by $0.04

Oct 29

CEO(最高経営責任者

Evelo Biosciences CEOがいない、あるいは彼らに関するデータがない。


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Craig Jalbert
Presidentless than a yearデータなしデータなし
Chun Zhang
Chief Technical Operations & Quality Officer4.8yrsデータなしデータなし
Mark Bodmer
Chief Scientific Officer and President of Research & Development8.6yrsUS$1.15m0.14%
$ 10.3
Jessica Cotrone
VP & Head of Communicationsno dataデータなしデータなし
Leslie Wardwell-Scott
VP and Head of Corporate Development & Strategic Integration2.4yrsデータなしデータなし
Andrea Itano
Head of Research4.8yrsデータなしデータなし
Duncan McHale
Chief Medical Officer6.8yrsUS$1.23m0.089%
$ 6.8
Douglas Maslin
Senior Director & Immunology Clinical Leadno dataデータなしデータなし

4.8yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: EVLOの経営陣は 経験豊富 であると考えられます ( 4.8年の平均在職年数)。